Sharda Cropchem (SHARDACROP)₹690.50+0.35%Pesticides & Agrochemicals
In the Sep 2026 quarter (consolidated), Sharda Cropchem reported sales of ₹1,051 Cr, up 13.3% from Sep 2025, and net profit of ₹91.73 Cr, up 24.2% year on year. For the year to Mar 2026, sales were ₹5,259 Cr and net profit ₹679 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 631 | 1,309 | 784 | 775 | 928 | 1,826 | 983 | 927 | 1,286 | 2,061 | 1,073 | 1,051 |
| Expenses | 561 | 1,053 | 706 | 685 | 812 | 1,519 | 768 | 794 | 1,045 | 1,574 | 885 | 886 |
| Operating Profit | 69.24 | 256 | 77.29 | 90.24 | 115 | 304 | 216 | 133 | 242 | 488 | 186 | 165 |
| OPM % | 11.0% | 19.0% | 9.9% | 11.9% | 12.0% | 17.0% | 21.9% | 14.0% | 19.0% | 23.9% | 16.9% | 15.9% |
| Other Income | 11.95 | −1.99 | 18.93 | 24.93 | 0.99 | 24.93 | 31.86 | 28.87 | 20.91 | 21.92 | 34.85 | 44.81 |
| Interest | 1.01 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 2.01 | 1.01 |
| Depreciation | 68.99 | 53.97 | 64.96 | 68.99 | 68.97 | 71.95 | 78.01 | 76.05 | 82.97 | 86.94 | 99.93 | 100 |
| Profit before tax | 12.02 | 198 | 31.03 | 46.05 | 46.09 | 256 | 169 | 86.10 | 179 | 423 | 118 | 107 |
| Tax % | 62.0% | 28.0% | 11.0% | 7.0% | 32.0% | 20.0% | 16.0% | 13.0% | 19.0% | 24.0% | 26.0% | 15.0% |
| Net Profit | 4.99 | 143 | 26.91 | 41.92 | 30.91 | 203 | 143 | 73.87 | 145 | 318 | 87.74 | 91.73 |
| EPS (Rs) | 0.52 | 15.92 | 3.03 | 4.71 | 3.46 | 22.61 | 15.84 | 8.25 | 16.10 | 35.39 | 9.77 | 10.19 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,221 | 1,397 | 1,705 | 1,994 | 1,999 | 2,392 | 3,573 | 4,042 | 3,156 | 4,313 | 5,259 | 5,471 |
| Expenses | 937 | 1,072 | 1,338 | 1,615 | 1,646 | 1,939 | 2,872 | 3,375 | 2,850 | 3,691 | 4,197 | 4,389 |
| Operating Profit | 282 | 325 | 365 | 377 | 351 | 452 | 698 | 661 | 304 | 617 | 1,062 | 1,081 |
| OPM % | 22.9% | 22.9% | 21.0% | 19.0% | 16.9% | 18.9% | 19.0% | 16.0% | 10.0% | 14.0% | 19.9% | 19.8% |
| Other Income | 22.92 | 13.95 | 8.97 | −21.93 | −11.95 | 45.85 | 28.90 | 39.86 | 59.81 | 59.82 | 141 | 122 |
| Interest | 8.02 | 9.03 | 15.03 | 20.07 | 16.04 | 16.04 | 15.05 | 20.04 | 24.07 | 21.05 | 21.07 | 3.02 |
| Depreciation | 35.01 | 55.97 | 69.95 | 99.01 | 137 | 170 | 245 | 248 | 267 | 275 | 325 | 370 |
| Profit before tax | 261 | 272 | 288 | 235 | 185 | 310 | 465 | 432 | 72.10 | 378 | 858 | 827 |
| Tax % | 33.0% | 30.0% | 34.0% | 25.0% | 11.0% | 26.0% | 25.0% | 21.0% | 56.0% | 20.0% | 20.0% | — |
| Exceptional items | −0.99 | −0.99 | −4.99 | −30.96 | −35.95 | 4.99 | 0.99 | 12.99 | 0.00 | 7.99 | 27.99 | — |
| Net Profit | 175 | 190 | 191 | 176 | 165 | 229 | 348 | 341 | 31.90 | 303 | 679 | 642 |
| EPS (Rs) | 19.43 | 21.14 | 21.17 | 19.59 | 18.27 | 25.42 | 38.75 | 37.98 | 3.54 | 33.81 | 75.61 | 71.45 |
| Dividend payout % | 21.0% | 19.0% | 19.0% | 20.0% | 22.0% | 20.0% | 16.0% | 16.0% | 85.0% | 27.0% | 20.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 90.05 | 90.02 | 89.98 | 90.03 | 90.05 | 89.97 | 90.01 | 90.01 | 90.02 | 90.05 | 90.02 | 89.95 |
| Reserves | 565 | 715 | 871 | 1,047 | 1,196 | 1,314 | 1,525 | 1,822 | 2,142 | 2,149 | 2,412 | 3,047 |
| Borrowings | 37.97 | 1.99 | 0.00 | 170 | 0.00 | 0.00 | 80.90 | 46.90 | 2.99 | 17.97 | 7.99 | 0.00 |
| Other Liabilities | 353 | 522 | 684 | 910 | 911 | 938 | 1,160 | 1,778 | 2,103 | 1,769 | 2,203 | 2,611 |
| Total Liabilities | 1,047 | 1,329 | 1,645 | 2,217 | 2,197 | 2,342 | 2,856 | 3,737 | 4,338 | 4,025 | 4,713 | 5,750 |
| Fixed Assets | 87.73 | 130 | 209 | 225 | 371 | 415 | 542 | 590 | 665 | 706 | 748 | 985 |
| CWIP | 149 | 210 | 232 | 361 | 220 | 161 | 131 | 212 | 204 | 284 | 292 | 247 |
| Investments | 95.32 | 90.26 | 61.20 | 22.06 | 213 | 116 | 83.20 | 134 | 32.08 | 159 | 295 | 362 |
| Other Assets | 715 | 899 | 1,142 | 1,609 | 1,393 | 1,650 | 2,098 | 2,800 | 3,436 | 2,876 | 3,377 | 4,154 |
| Inventories | 140 | 160 | 287 | 529 | 364 | 381 | 525 | 891 | 1,132 | 990 | 970 | 1,118 |
| Trade receivables | 456 | 621 | 675 | 895 | 813 | 992 | 1,166 | 1,543 | 1,838 | 1,501 | 1,960 | 2,394 |
| Cash & equivalents | 70.12 | 65.12 | 108 | 101 | 124 | 153 | 262 | 166 | 182 | 88.29 | 221 | 221 |
| Total Assets | 1,047 | 1,329 | 1,645 | 2,217 | 2,197 | 2,342 | 2,856 | 3,737 | 4,338 | 4,025 | 4,713 | 5,750 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 45.99 | 197 | 181 | 16.99 | 555 | 146 | 246 | 267 | 328 | 341 | 603 | 656 |
| Cash from investing activity | −19.02 | −113 | −104 | −160 | −351 | −59.02 | −282 | −205 | −112 | −393 | −496 | −445 |
| Cash from financing activity | −24.09 | −89.36 | −38.14 | 133 | −216 | −60.25 | 43.18 | −91.40 | −97.38 | −37.14 | −68.24 | −118 |
| Net cash flow | 3.01 | −6.02 | 40.13 | −11.04 | −11.03 | 27.09 | 8.03 | −29.09 | 120 | −89.19 | 40.11 | 93.25 |
| Capex | 79.91 | 0.00 | 142 | 202 | 143 | 176 | 231 | 234 | 244 | 272 | 393 | 497 |
| Free cash flow | −33.96 | 196 | 38.92 | −185 | 413 | −29.97 | 14.97 | 32.96 | 83.91 | 68.94 | 211 | 158 |
| CFO / OP % | 58.0% | 95.0% | 73.0% | 27.0% | 169.0% | 60.0% | 68.0% | 49.0% | 60.0% | 129.0% | 103.0% | 68.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 156 | 185 | 175 | 191 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 166 |
| Inventory days | 73 | 75 | 118 | 170 | 97 | 101 | 118 | 131 | 146 | 156 | 118 | 122 |
| Days payable | 118 | 180 | 187 | 203 | 168 | 181 | 181 | 173 | 177 | 145 | 159 | 163 |
| Cash conversion cycle | 111 | 81 | 106 | 158 | 77 | 100 | 114 | 115 | 134 | 184 | 124 | 125 |
| Working capital days | 83 | 96 | 100 | 95 | 72 | 102 | 95 | 89 | 98 | 129 | 93 | 103 |
| ROCE % | 27.1% | 36.1% | 32.1% | 27.1% | 23.1% | 18.1% | 21.1% | 26.1% | 21.1% | 4.0% | 16.1% | 30.1% |
For the Sep 2026 quarter, Sharda Cropchem reported sales of ₹1,051 Cr, up 13.3% year on year and net profit of ₹91.73 Cr, up 24.2% year on year. The operating margin was 15.9%.
Sharda Cropchem's sales for the year to Mar 2026 were ₹5,259 Cr; over the last twelve months they were ₹5,471 Cr.
Net profit for the year to Mar 2026 was ₹679 Cr, and ₹642 Cr over the last twelve months. Earnings per share over the same trailing period were ₹71.45.
Sharda Cropchem reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹221 Cr.
Cash from operations was ₹656 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹158 Cr.